MarketInOut Stock Screener Log In | Sign Up
 

Fortress Biotech Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 05/08/2026
Fortress Biotech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization79.73 mln
Float22.07 mln
Earnings Date05/15/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-0.12
Highly suspicious

Relative Strength

66 / 100
Outperforming

Debt / Equity

1.49
Elevated leverage

ROE

17.51
Healthy

Dividend Yield

0.00%
No dividend

Business Description

Fortress Biotech is a Florida-based pharmaceutical company that develops and sells a wide range of medical treatments, with a particular focus on skin conditions such as acne, rosacea, and fungal infections. Beyond dermatology, the company is advancing treatments for serious illnesses including cancer, rare genetic disorders, and post-surgical pain. It also has a growing pipeline of early and pre-clinical therapies spanning areas such as gout, brain tumors, and gene therapy. Founded in 2006 and originally known as Coronado Biosciences, the company works across multiple stages of drug development, from early research through to commercial sales.

Key Fundamentals

EPS-0.07
ROE17.51
RPS2.11
ROIC-107
ROA4.01
EBITDA, mln-20.34
EV / EBITDA-3.97
EV / EBIT-3.23
Revenue, mln63.26
EV / Revenue1.27

Financial Strength

Altman Z-Score-4.8
Piotroski F-Score 6 / 9
Beneish M-Score-0.12
Short Ratio8.89
Short % of Float17.51

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.58% 73 / 100   
1 Month -0.42% 25 / 100   
2 Months -22.9% 15 / 100   
6 Months -3.63% 34 / 100   
1 Year 38.95% 74 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us